The MICELab group has the most important hardware and software required to develop research tasks in technologies for diabetes, including software licenses, access to databases, scientific journals and library access. In addition, we have the following unique infrastructure:
Our Android-based AP platform (jAP) is a multivariable fully automated artificial pancreas. The jAP system stands out for its scalability, allowing the implementation of unihormonal, bihormonal systems and easily integrating additional devices such as physical activity monitors. It is one of the few platforms available internationally.
As a result of different studies we have collected data on more than 120 patients (over 2000 hours of continuous monitoring / control) in both open- and closed-loop. This information is used for modelling, study of continuous glucose monitors, therapy assessment and control.
This simulator has currently five groups of patients, including intra-patient variability (circadian rhythms other variations of lower frequency). It includes a library with effects from consuming mixed meals and making exercise. It also has the ability to simulate failures in sensors and insulin pumps. About this simulator someone can try different therapies and control strategies in both open- and closed-loop.
We have developed a hardware and software platform based on LabVIEW for implementation and validation of drivers glucose (CL4M controls). The first version of the platform has been validated and approved by the Spanish Agency for Medicines and Health care Products (AEMPS).